M&A TRANSACTION · 2023
NextGen Healthcare acquired by Thoma Bravo
$1.80B· 16.1x EBITDA· 2.80x revenue
Target
NextGen Healthcare
Acquirer
Thoma Bravo
Private Equity buyer
Disclosed financials at time of acquisition
Revenue
$653.2M
EBITDA
$111.7M
Deal Value
$1.80B
EV/EBITDA
16.1x
Context
This $1.80B acquisition of NextGen Healthcare by Thoma Bravo sits in the healthtech sub-vertical. The 16.1x EBITDA multiple paid in 2023 can be compared against the population median for healthtech transactions of similar size on our Healthtech valuation hub. Thoma Bravo is acquiring as a private equity buyer; see how PE acquirers typically price healthtech businesses on our Healthtech PE buyer-pool page.
Source
Data sourced from SEC Fairness Opinion — primary source. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own healthtech
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
Compare your business to the NextGen Healthcare acquisition.